The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Slides:



Advertisements
Similar presentations
1 Familial Hypercholesterolemia (FH): Premature Cardiovascular Risk Reduction Through Early Action.
Advertisements

ATHEROSCLEROSIS THE HDL RECEPTORS A REVIEW AND
The future of HDL raising
Update from the IAS 2012 Jonathan Silberberg March 2012.
Genetic Variants Associated with Late-Onset Alzheimer Disease By: Sarah Hinton, University of Georgia 2014 Pharm.D. candidate Preceptor: Dr. Ali Rahimi.
New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention Prof. Ulf Landmesser University Hospital Zürich Switzerland.
KEY CONCEPT A combination of methods is used to study human genetics.
Metabolism of HDL Dr Nikhat Siddiqi.
Friend or Foe? High HDL Cholesterol. High Density Lipoprotein Origin: liver Content: 18-25% TC content 45-55% Protein 2-7% TG 20-30% Phospholipids Density:
HDL mediated efflux of cholesterol from the arterial wall: Can HDL promote removal of cholesterol from atherosclerotic lesions? Prof. John Chapman INSERM,
Molecular Medicine and Gene Therapy. Monogenetic Disorders – Single gene pathway – Multi gene pathway: But one gene only mutated Multifactorial Disorder.
Plasma lipoproteins. Generalized structure of a plasma lipoprotein.
Dr Abdul Lateef Assistant professor Dept of Biochemistry.
Cholesterol Metabolism Southwestern Medical School Dallas, Texas.
KEY CONCEPT A combination of methods is used to study human genetics.
بسم الله الرحمن الرحيم.
Lipid Homeostasis and Transport CH353 February 12, 2008.
Low HDL remains a predictor of cardio- vascular risk in statin-treated patients Barter P et al., N Engl J Med 2007; 357:
Genetic disorders can be due to any of the following factors: A. Monogenetic Disorders: Caused by a mutation in a single gene 1. Autosomal recessive alleles:
The Future of Genetics Research Lesson 7. Human Genome Project 13 year project to sequence human genome and other species (fruit fly, mice yeast, nematodes,
CONTACT NUMBERS TEL:(202) FAX: (202) DR. RAJ LAKSHMAN PROFESSOR OF BIOCHEMISTRY, MOLECULAR BIOLOGY & MEDICINE.
Gene Technologies and Human ApplicationsSection 1 Section 1: The Human Genome Preview Bellringer Key Ideas Secrets of the Human Genome Applications of.
Size and apolipoprotein composition are the main factors determining atherogenicity of triglyceride-rich particles.
The Endocrine System (the body’s chemical messenger system)
Lipoproteins and Atheroscloresis
Lipoproteins and Atheroscloresis
بسم الله الرحمن الرحيم.
Perelman School of Medicine University of Pennsylvania
HDL-cholesterol versus apoA-I and Atherosclerosis Regression
KEY CONCEPT A combination of methods is used to study human genetics.
KEY CONCEPT A combination of methods is used to study human genetics.
Is atherosclerosis a metabolic disease?
Plasma Lipid Transport Role of HDL
Working Groups (thematic description)
HDL and Atherosclerosis
Paul Durrington  Atherosclerosis Supplements 
KEY CONCEPT A combination of methods is used to study human genetics.
Figure 1 Evolution of genetic concepts underlying risk of cardiovascular disease Figure 1 | Evolution of genetic concepts underlying risk of cardiovascular.
KEY CONCEPT A combination of methods is used to study human genetics.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
KEY CONCEPT A combination of methods is used to study human genetics.
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Figure 1 Overview of lipoprotein metabolism and effects of novel lipid-modulating approaches Figure 1 | Overview of lipoprotein metabolism and effects.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Acute-phase HDL
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Volume 7, Issue 5, Pages (May 2008)
KEY CONCEPT A combination of methods is used to study human genetics.
HDL and Atherosclerosis
Sophie Stukas, Jérôme Robert, Cheryl L. Wellington  Cell Metabolism 
Volume 17, Issue 4, Pages (April 2013)
Interaction of hypercholesterolemia and inflammation in atherogenesis
KEY CONCEPT A combination of methods is used to study human genetics.
New Therapeutic Approaches to the Treatment of Dyslipidemia
K June 03 03/06/20 1.
Class Notes #8: Genetic Disorders
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Volume 7, Issue 5, Pages (May 2008)
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Nat. Rev. Nephrol. doi: /nrneph
Carrier = an organism that has inherited a genetic trait or mutation, but displays no symptoms X-linked traits = traits that are passed on from parents.
KEY CONCEPT A combination of methods is used to study human genetics.
Potential Mechanisms of Adverse Outcomes Associated with Torcetrapib
KEY CONCEPT A combination of methods is used to study human genetics.
Reverse cholesterol transport CETP is key in remodeling of HDL
KEY CONCEPT A combination of methods is used to study human genetics.
Sophie Stukas, Jérôme Robert, Cheryl L. Wellington  Cell Metabolism 
KEY CONCEPT Entire genomes are sequenced, studied, and compared.
KEY CONCEPT A combination of methods is used to study human genetics.
Presentation transcript:

The role of HDL in atherosclerosis Prof. M. John Chapman (Paris, France) in discussion with Dr. Kees Hovingh (Amsterdam, The Netherlands)

Genetics (1) What is the relationship between functional mutations in the major genes involved in HDL metabolism and cardiovascular risk?

Genetics of HDL metabolism (1) Studying families with carries of mutations Mutations in LCAT, ABCA1, ApoA-1

HDL metabolism

Genetics of HDL metabolism (2) Relatively small number of subjects Heterozygous carriers: increased IMT Lack of large numbers and relevance of the genes Different groups showing different data ApoA-1, one of the best targets of atherosclerosis

ApoA-1

Genetics (2) Should we widen our studies of the key genes within a specific family or cohort?

Genetics of HDL metabolism (2) Individual with SRB1 mutation, but a low-normal HDL level: counterintuitive Sequencing ApoA-1, LCAT and ABCA1 Neutralizing effects of other monogenetic disorders: HDL level and CAD risk Sequencing a lot of genes all at once Better view of the landscape of genetic disorders underpinning HDL levels

Systems biology Is this approach comparable with systems biology?

Systems biology (1) Measure enzymatic endpoints Concept: impact of a gene on the phenotype We might have been using the wrong system

Systems biology (2) Our field: primarily focused on murine cell lines Also human cell lines: little relation to the profile in in vitro cultured macrophages

HDL-mediated cholesterol efflux from cholesterol-rich macrophages apo E apo A-1 Rader DJ. J Clin Invest. 2006;116:3090–3100.

Systems biology (3) Effort to define standard culture conditions Complexity of the HDL or ApoA-1 ligand

Mechanisms of cellular cholesterol efflux to HDL particles

HDL metabolism: impact of CETP inhibition

Systems biology (4) CETP: most significant gene (genome studies) Reevaluate our ex vivo/in vitro approaches

Controversy Is the controversy mainly associated with the systems that have been used?

Controversy Great deal of difference between the expression of these receptors, not only in macrophages from different species, but also in human conditions